SCHEMBL6662616

SCHEMBL6662616

COC(=O)[C@H](Cc1ccc(OCc2ccccc2)cc1)NC(=O)c1c(OC)cccc1OC

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.60
GAA P10253 1/20 0.59
RAB9A P51151 1/20 0.59
LTA4H P09960 1/20 0.55
YAP1 P46937 5/20 0.54
ABCG2 Q9UNQ0 1/20 0.54
ERAP2 Q6P179 1/20 0.53
LNPEP Q9UIQ6 1/20 0.53
ATM Q13315 1/20 0.51
GPR132 Q9UNW8 1/20 0.51
MEN1 O00255 1/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
KMT2A Q03164 1/20 0.51
GPR34 Q9UPC5 1/20 0.51
MMP9 P14780 1/20 0.51
MMP8 P22894 1/20 0.51
TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6516668 0.92 PPARG (0.61) PPARGGAAGPR132ALDH1A1GPR34
SCHEMBL1122843 0.85 GAA (0.67) PPARGGAARAB9ALTA4HYAP1
SCHEMBL1123055 0.85 GAA (0.80) PPARGGAARAB9ALTA4HYAP1
SCHEMBL1123122 0.85 RAB9A (0.66) PPARGGAARAB9ALTA4HYAP1
SCHEMBL16552342 0.83 PPARG (0.69) PPARGGAARAB9ALTA4HYAP1
SCHEMBL1122743 0.83 GPR132 (0.76) PPARGGAARAB9AYAP1ERAP2
SCHEMBL1122705 0.83 GPR132 (0.76) PPARGGAARAB9AYAP1ERAP2
SCHEMBL1122834 0.82 GAA (0.75) PPARGGAARAB9ALTA4HYAP1
SCHEMBL1122925 0.82 GAA (0.75) PPARGGAARAB9ALTA4HYAP1
SCHEMBL1122839 0.82 GAA (0.68) PPARGGAARAB9ALTA4HYAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056714-B1 PHENYLALANINE DERIVATIVES AS INHIBITORS OF ALPHA4 INTEGRINS CELLTECH THERAPEUTICS LTD (GB) 2004-08-11 EP disclosed
US-6555562-B1 2-Carboxybenzoyl-(N'-3,5-dichloroisonicotinoyl)-L-4aminophenyl alanine, for example; inhibit the binding of alpha-4 integrins to their ligands, use to treat immune or inflammatory disorders CELLTECH R&D LIMITED (GB) 2003-04-29 US disclosed